Cite
Levetiracetam Ameliorates L-DOPA-Induced Dyskinesia in Hemiparkinsonian Rats Inducing Critical Molecular Changes in the Striatum.
MLA
Du, Huan, et al. “Levetiracetam Ameliorates L-DOPA-Induced Dyskinesia in Hemiparkinsonian Rats Inducing Critical Molecular Changes in the Striatum.” Parkinson’s Disease (20420080), vol. 2015, Jan. 2015, pp. 1–9. EBSCOhost, https://doi.org/10.1155/2015/253878.
APA
Du, H., Nie, S., Chen, G., Ma, K., Xu, Y., Zhang, Z., Papa, S. M., & Cao, X. (2015). Levetiracetam Ameliorates L-DOPA-Induced Dyskinesia in Hemiparkinsonian Rats Inducing Critical Molecular Changes in the Striatum. Parkinson’s Disease (20420080), 2015, 1–9. https://doi.org/10.1155/2015/253878
Chicago
Du, Huan, Shuke Nie, Guiqin Chen, Kai Ma, Yan Xu, Zhentao Zhang, Stella M. Papa, and Xuebing Cao. 2015. “Levetiracetam Ameliorates L-DOPA-Induced Dyskinesia in Hemiparkinsonian Rats Inducing Critical Molecular Changes in the Striatum.” Parkinson’s Disease (20420080) 2015 (January): 1–9. doi:10.1155/2015/253878.